About IsoCanMed
IsoCanMed was established in 2017 in Louiseville, Canada. Operations are centered on the manufacturing of cannabis-based products within the health and wellness sector. Production processes are conducted to meet regulatory standards for cannabis derivatives. The company maintains its primary facility in Canada, supporting distribution in the North American market. Focus remains on quality-controlled output for various applications in the industry.
- Headquarter Louiseville, Canada
-
Sectors
Consumer
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Mtl Cannabis
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
Canada House
(May 29, 2020)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of IsoCanMed
Detailed funding history for IsoCanMed
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in IsoCanMed
IsoCanMed has secured backing from 1 investor. Prominent investors backing the company include Canada House.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Medical-grade cannabis is cultivated and cannabinoid therapy is provided globally.
|
Locked | Locked | Locked |
Investor details for IsoCanMed
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by IsoCanMed
Investment portfolio details for IsoCanMed
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - IsoCanMed
Detailed financials for IsoCanMed
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Isocanmed Comparisons
Peer comparison for IsoCanMed
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of IsoCanMed
Detailed competitors of IsoCanMed
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Isocanmed
Complete news archive for IsoCanMed
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about IsoCanMed
IsoCanMed was founded in 2017.
IsoCanMed is headquartered in Louiseville, Canada. It is registered at Louiseville, Quebec, Canada.
IsoCanMed was established in 2017 in Louiseville, Canada. Operations are centered on the manufacturing of cannabis-based products within the health and wellness sector. Production processes are conducted to meet regulatory standards for cannabis derivatives. The company maintains its primary facility in Canada, supporting distribution in the North American market. Focus remains on quality-controlled output for various applications in the industry.
IsoCanMed has 1 investor. Key investors include Canada House.